Veterinary / Animal Vaccines Market by Product (Livestock, Companion,
Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

Table of Contents

1 INTRODUCTION 17

1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22

2.1 MARKET SIZE ESTIMATION 23
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.2.1 KEY DATA FROM SECONDARY SOURCES 27
2.2.2 KEY DATA FROM PRIMARY SOURCES 27
2.2.2.1 Key industry insights 28
2.2.3 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33

4.1 VETERINARY VACCINES MARKET TO GROW AT A STEADY RATE 33
4.2 VETERINARY VACCINES MARKET, BY PRODUCT 33
4.3 VETERINARY VACCINES MARKET, BY REGION 34
4.4 VETERINARY VACCINES MARKET, BY TECHNOLOGY 34
4.5 LIFECYCLE ANALYSIS, BY REGION 35

5 MARKET OVERVIEW 36

5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.3 MARKET DYNAMICS 38
5.3.1 DRIVERS 38
5.3.1.1 Increase in livestock and instances of disease 38
5.3.1.2 Increasing incidence of zoonotic diseases 39
5.3.1.3 Increasing investments by various government agencies, animal associations, and leading players 39
5.3.1.4 Introduction of new types of vaccines 39
5.3.2 RESTRAINTS 40
5.3.2.1 Rising maintenance costs for storage of vaccines 40
5.3.2.2 Increasing prices of meat promoting the rise in adoption of vegetarian diets 41
5.3.3 OPPORTUNITIES 41
5.3.3.1 Technological innovations such as DNA vaccines 41
5.3.3.2 Growing awareness of animal health in emerging economies 42

6 VETERINARY VACCINES MARKET, BY PRODUCT 43

6.1 INTRODUCTION 44

7 VETERINARY VACCINES MARKET, BY DISEASE 46

7.1 INTRODUCTION 47
7.2 PORCINE VACCINES 47
7.2.1 SNAPSHOT: MARKET SHARE, BY DISEASE 47
7.3 POULTRY VACCINES 49
7.3.1 SNAPSHOT: MARKET SHARE, BY DISEASE 49
7.4 COMPANION ANIMAL VACCINES 51
7.5 CANINE VACCINES 51
7.5.1 SNAPSHOT: MARKET SHARE, BY DISEASE 51
7.6 FELINE VACCINES 53
7.6.1 SNAPSHOT: MARKET SHARE, BY DISEASE 53
7.7 LIVESTOCK VACCINES 54
7.7.1 BOVINE VACCINES 54
7.7.1.1 Snapshot: Market Share, by Disease 54
7.7.2 SMALL RUMINANT VACCINES 56
7.7.2.1 Snapshot: Market Share, by Disease 56
7.8 EQUINE VACCINES 57
7.8.1 SNAPSHOT: MARKET SHARE, BY DISEASE 57
7.9 AQUACULTURE VACCINES 59
7.9.1 SNAPSHOT: MARKET SHARE, BY DISEASE 59

8 VETERINARY VACCINES MARKET, BY TECHNOLOGY 61

8.1 INTRODUCTION 62
8.2 LIVE ATTENUATED VACCINES (LAV) 63
8.3 INACTIVATED VACCINES 65
8.4 TOXOID VACCINES 67
8.5 RECOMBINANT VACCINES 68
8.6 CONJUGATE VACCINES 69
8.7 SUBUNIT VACCINES 71
8.8 DNA VACCINES 73
 

9 VETERINARY VACCINES MARKET, BY REGION 74

9.1 INTRODUCTION 75
9.2 EUROPE 78
9.3 NORTH AMERICA 90
9.4 ASIA 100
9.4.1 CHINA 101
9.4.2 THAILAND 110
9.4.2.1 Regulatory landscape for veterinary vaccines in Thailand 111
9.4.3 INDIA 119
9.5 REST OF THE WORLD (ROW) 130
9.5.1 BRAZIL 130

10 COMPETITIVE LANDSCAPE 140

10.1 OVERVIEW 141
10.2 MARKET SHARE ANALYSIS 142
10.3 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS, BY PRODUCT (2013–2015) 143
10.3.1 RECENT DEVELOPMENTS BY MARKET PLAYERS (2013–2015) 144
10.3.1.1 Zoetis (Pfizer) 144
10.3.1.2 Merck Animal Health 144
10.3.1.3 Boehringer Ingelheim 145
10.3.1.4 Ceva Animal Health 145
10.4 COMPETITIVE SITUATION AND TRENDS 146
10.4.1 NEW PRODUCT LAUNCHES 146
10.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 147
10.4.3 ACQUISITIONS 148
10.4.4 EXPANSION 149
10.4.5 OTHER DEVELOPMENTS 149

11 COMPANY PROFILES 150

(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 150
11.2 BAYER HEALTHCARE 151
11.3 BIONICHE ANIMAL HEALTH 153
11.4 BOEHRINGER INGELHEIM 155
11.5 CEVA ANIMAL HEALTH 159
11.6 ELANCO ANIMAL HEALTH (ELI LILLY) 161
11.7 HESKA CORPORATION 164
11.8 MERCK ANIMAL HEALTHCARE 166
11.9 MERIAL INC. (SANOFI) 169
11.10 VIRBAC 171
11.11 ZOETIS 173
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12 APPENDIX 176

12.1 INSIGHTS OF INDUSTRY EXPERTS 176
12.2 DISCUSSION GUIDE 177
12.3 OTHER COMPANY DEVELOPMENTS (2013–2014) 180
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 183
12.5 AVAILABLE CUSTOMIZATIONS 184
12.6 RELATED REPORTS 185

LIST OF TABLES

TABLE 1 GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE THE VETERINARY VACCINES MARKET 40
TABLE 2 HIGH MAINTENANCE AND STORAGE COST OF VACCINES TO RESTRAIN MARKET GROWTH 41
TABLE 3 TECHNOLOGICAL ADVANCEMENTS LIKELY TO BOOST THE VETERINARY VACCINES MARKET 42
TABLE 4 VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION) 45
TABLE 5 PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 48
TABLE 6 POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 50
TABLE 7 CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 52
TABLE 8 FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 54
TABLE 9 BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 55
TABLE 10 SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 57
TABLE 11 EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 58
TABLE 12 AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 60
TABLE 13 VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 63
TABLE 14 LIVE ATTENUATED VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 64
TABLE 15 INACTIVATED VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 66
TABLE 16 TOXOID VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 67
TABLE 17 RECOMBINANT VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 68
TABLE 18 CONJUGATE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 70
TABLE 19 SUBUNIT VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 72
TABLE 20 DNA VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 73
TABLE 21 VETERINARY VACCINES MARKET SIZE, BY REGION, 2013–2020 ($MILLION) 77
TABLE 22 EUROPE: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 80
TABLE 23 EUROPE: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 81
TABLE 24 EUROPE: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 82
TABLE 25 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 82
TABLE 26 EUROPE: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 83
TABLE 27 EUROPE: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 83
TABLE 28 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 84
TABLE 29 EUROPE: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 84
TABLE 30 EUROPE: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 85
TABLE 31 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 86
TABLE 32 EUROPE: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 86
TABLE 33 EUROPE: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 87
TABLE 34 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 87
TABLE 35 EUROPE: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 88
TABLE 36 EUROPE: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 88
TABLE 37 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 89
TABLE 38 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 89
TABLE 39 NORTH AMERICA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 91
TABLE 40 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 91
TABLE 41 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 92
TABLE 42 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 92
TABLE 43 NORTH AMERICA: BOVINE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 93
TABLE 44 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 93
TABLE 45 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 94
TABLE 46 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 95
TABLE 47 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 95
TABLE 48 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE,
BY CATEGORY, 2013–2020 ($MILLION) 96
TABLE 49 NORTH AMERICA: CANINE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 96
TABLE 50 NORTH AMERICA: FELINE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 96
TABLE 51 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE,
BY TECHNOLOGY, 2013–2020 ($MILLION) 97
TABLE 52 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 97
TABLE 53 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 98
TABLE 54 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 98
TABLE 55 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 99
TABLE 56 CHINA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 102
TABLE 57 CHINA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 102
TABLE 58 CHINA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 103
TABLE 59 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 104
TABLE 60 CHINA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 104
TABLE 61 CHINA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 105
TABLE 62 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 105
TABLE 63 CHINA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 106
TABLE 64 CHINA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 106
TABLE 65 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 107
TABLE 66 CHINA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 107
TABLE 67 CHINA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 107
TABLE 68 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 108
TABLE 69 CHINA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 108
TABLE 70 CHINA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 109
TABLE 71 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 109
TABLE 72 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 110
TABLE 73 THAILAND: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 112
TABLE 74 THAILAND: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 113
TABLE 75 THAILAND: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 113
TABLE 76 THAILAND: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 114
TABLE 77 THAILAND: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 115
TABLE 78 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 115
TABLE 79 THAILAND: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 116
TABLE 80 THAILAND: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 116
TABLE 81 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 117
TABLE 82 THAILAND: LIVESTOCK ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 117
TABLE 83 THAILAND: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 118
TABLE 84 THAILAND: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 118
TABLE 85 THAILAND: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 119
TABLE 86 INDIA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 120
TABLE 87 INDIA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 121
TABLE 88 INDIA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 121
TABLE 89 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 122
TABLE 90 INDIA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 122
TABLE 91 INDIA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 123
TABLE 92 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 124
TABLE 93 INDIA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 124
TABLE 94 INDIA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 125
TABLE 95 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 125
TABLE 96 INDIA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 126
TABLE 97 INDIA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 126
TABLE 98 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 127
TABLE 99 INDIA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 127
TABLE 100 INDIA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 128
TABLE 101 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 128
TABLE 102 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 129
TABLE 103 BRAZIL: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 131
TABLE 104 BRAZIL: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 131
TABLE 105 BRAZIL: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 132
TABLE 106 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 132
TABLE 107 BRAZIL: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 133
TABLE 108 BRAZIL: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 133
TABLE 109 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 134
TABLE 110 BRAZIL: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 134
TABLE 111 BRAZIL: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 135
TABLE 112 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2013–2020 ($MILLION) 136
TABLE 113 BRAZIL: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 136
TABLE 114 BRAZIL: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 137
TABLE 115 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 137
TABLE 116 BRAZIL: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 138
TABLE 117 BRAZIL: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 138
TABLE 118 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2013–2020 ($MILLION) 139
TABLE 119 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION) 139
TABLE 120 NEW PRODUCT LAUNCHES, 2013–2015 146
TABLE 121 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2015 147
TABLE 122 ACQUISITIONS, 2013-2015 148
TABLE 123 EXPANSIONS, 2013-2015 149
TABLE 124 OTHER DEVELOPMENTS, 2012–2015 149

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET 22
FIGURE 2 MARKET SIZE ESTIMATION APPROCH 24
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25
FIGURE 4 DATA TRIANGULATION METHODOLOGY 26
FIGURE 5 VETERINARY VACCINES MARKET SNAPSHOT (2015 VS. 2020): COMPANION ANIMAL VACCINES SEGMENT TO GROW AT THE HIGHEST CAGR 29
FIGURE 6 LIVE ATTENUATED VACCINES SEGMENT IS EXPECTED TO DOMINATE THE VETERINARY VACCINES TECHNOLOGIES MARKET IN 2015 30
FIGURE 7 PORCINE CIRCOVIRUS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE PORCINE VACCINES MARKET 31
FIGURE 8 CANINE RABIES VACCINES SEGMENT WILL CONTINUE TO DOMINATE THE CANINE VACCINES MARKET 31
FIGURE 9 ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 32
FIGURE 10 ATTRACTIVE MARKET OPPORTUNITIES 33
FIGURE 11 PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN 2014 33
FIGURE 12 ASIA IS EXPECTED TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD 34
FIGURE 13 LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT IS EXPECTED TO DOMINATE THE VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD 34
FIGURE 14 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 35
FIGURE 15 INCREASING INCIDENCE OF ZOONOTIC DISEASES TO BOOST MARKET GROWTH 38
FIGURE 16 PORCINE VACCINES COMMANDED LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN 2014 44
FIGURE 17 PORCINE CIRCOVIRUS SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN PORCINE VACCINES MARKET, BY 2020 48
FIGURE 18 INFECTIOUS BRONCHITIS SEGMENT DOMINATED THE POULTRY VACCINES MARKET IN 2014 50
FIGURE 19 CANINE DISTEMPER SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN CANINE VACCINES MARKET BY 2020 52
FIGURE 20 FELINE RABIES SEGMENT DOMINATED FELINE VACCINES MARKET IN 2014 53
FIGURE 21 BVD SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN BOVINE VACCINES MARKET BY 2020 55
FIGURE 22 CLOSTRIDIAL DISEASES SEGMENT DOMINATED THE SMALL RUMINANT VACCINES MARKET IN 2014 56
FIGURE 23 EQUINE RHINOPNEUMONITIS SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN EQUINE VACCINES MARKET BY 2020 58
FIGURE 24 VIBRIOSIS SEGMENT DOMINATED THE AQUACULTURE VACCINES MARKET IN 2014 59
FIGURE 25 LIVE ATTENUATED VACCINES DOMINATED THE GLOBAL VETERINARY VACCINES MARKET IN 2014 62
FIGURE 26 POULTRY VACCINES DOMINATED THE LIVE ATTENUATED VACCINES MARKET IN 2014 64
FIGURE 27 COMPANION ANIMAL VACCINES TO WITNESS THE HIGHEST GROWTH RATE IN THE INACTIVATED VACCINES MARKET BY 2020 65
FIGURE 28 LIVESTOCK VACCINES DOMINATED THE TOXOID VACCINES MARKET IN 2014 67
FIGURE 29 PORCINE VACCINES TO GROW AT THE HIGHEST RATE IN THE RECOMBINANT VACCINES MARKET BY 2020 68
FIGURE 30 PORCINE VACCINES DOMINATED THE CONJUGATE VACCINES MARKET IN 2014 69
FIGURE 31 LIVESTOCK VACCINES TO GROW AT THE HIGHEST RATE IN THE SUBUNIT VACCINES MARKET BY 2020 71
FIGURE 32 PORCINE VACCINES DOMINATED THE DNA VACCINES MARKET IN 2014 73
FIGURE 33 GEOGRAPHIC SNAPSHOT ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 75
FIGURE 34 ASIA, AN ATTRACTIVE DESTINATION FOR ALL PRODUCT CATEGORIES 76
FIGURE 35 EUROPE WILL CONTINUE TO LEAD THE GLOBAL VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 76
FIGURE 36 THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY THE GROWING PRODUCTION OF PIG MEAT IN THE FORECAST PERIOD 79
FIGURE 37 THE PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN VETERINARY VACCINES MARKET, BY PRODUCT 80
FIGURE 38 RECOMBINANT VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN EUROPEAN VETERINARY VACCINESMARKET IN THE FORECAST PERIOD 81
FIGURE 39 THE INACTIVATED VACCINES TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN COMPANION ANIMAL VACCINES MARKET 85
FIGURE 40 COMPANION ANIMAL VACCINES WILL BE THE FASTEST-GROWING SEGMENT FOR NORTH AMERICAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 90
FIGURE 41 THE LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICA LIVESTOCK VACCINES MARKET 94
FIGURE 42 ASIA MARKET SNAPSHOT: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY INCREASING INCIDENCES OF ZOONOTIC DISEASES 100
FIGURE 43 THE LIVESTOCK VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN CHINA 101
FIGURE 44 CONJUGATE VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT FOR ASIAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 103
FIGURE 45 THE PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE THAILAND VETERINARY VACCINES MARKET 112
FIGURE 46 RECOMBINANT VACCINE TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH THAILAND VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 114
FIGURE 47 THE LIVESTOCK VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN INDIA 120
FIGURE 48 CONJUGATE VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN LIVESTOCK VACCINES MARKET THE FORECAST PERIOD 123
FIGURE 49 THE POULTRY VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN BRAZIL 130
FIGURE 50 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO GROW AT THE HIGHEST CAGR IN POULTRY VACCINES MARKET IN THE FORECAST PERIOD 135
FIGURE 51 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AND LICENSES AS THEIR KEY GROWTH STRATEGY (2013-2015) 141
FIGURE 52 GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2014 142
FIGURE 53 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2015) 143
FIGURE 54 ZOETIS (PFIZER) FOCUSED ON PORCINE SEGMENT IN LAST FEW YEARS
(2013-2015) 144
FIGURE 55 MERCK CONCENTRATED ON LIVESTOCK SEGMENT (2013-2015) 144
FIGURE 56 BOEHRINGER INGELHEIM MAINLY CONCENTRATED ON EQUINE SEGMENT (2013-2015) 145
FIGURE 57 CEVA RELEASED NEW PRODUCTS FOR THE POULTRY SEGMENT (2013 – 2015) 145
FIGURE 58 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY 146
FIGURE 59 GEOGRAPHIC REVENUE MIX OF TOP FIVE MARKET PLAYERS 150
FIGURE 60 BAYER HEALTHCARE: COMPANY SNAPSHOT 151
FIGURE 61 BIONICHE ANIMAL HEALTH: COMPANY SNAPSHOT 153
FIGURE 62 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT 155
FIGURE 63 CEVA ANIMAL HEALTH: COMPANY SNAPSHOT 159
FIGURE 64 ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT 161
FIGURE 65 HESKA CORPORATION: COMPANY SNAPSHOT 164
FIGURE 66 MERCK ANIMAL HEALTHCARE: COMPANY SNAPSHOT 166
FIGURE 67 MERIAL INC. (SANOFI): COMPANY SNAPSHOT 169
FIGURE 68 VIRBAC: COMPANY SNAPSHOT 171
FIGURE 69 ZOETIS: COMPANY SNAPSHOT 173

当レポートのプレスリリースは発行されておりません。